Global X FTSE Andean 40 ETF AND
No live quote for AND yet.
- Previous close
- 16.27
No chart data for this range yet.
Key statistics
- Price / sales
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- 50-day average
- 1.00
- 200-day average
- 1.00
Next earnings
Consensus EPS estimate 0.00.
News
Teva Pharmaceuticals International Granted Exclusive Rights To Commercialize Formulations For Polpharma Biologics’ Proposed Biosimilar To Ocrevus 
Teva Pharma And Polpharma Biologics Announce Global Licensing Agreement Granting Teva Exclusive Rights To Commercialize Both Formulations Of Polpharma Biologics’ Proposed Biosimilar To Ocrevus, Upon Regulatory Approval 
Teva Pharmaceutical Industries Subsidiary And Medincell Says European Medicines Agency Has Accepted The Marketing Authorization Application For Olanzapine Long-Acting Injectable (TEV-'749) For The Treatment Of Schizophrenia In Adults - Some Niche ETFs Seeing Decent Inflows
Five Emerging Markets ETFs for the Second Half (AND, THD, TUR) - ETFs: Looking For Strength in All The Right Places (XLY, FCG, VNM)
- New Kids On The Block: Global X's Top New ETFs
Five Multi-Country EM ETFs To Consider - Global X Tops $1.5 Billion In AUM
February ETF Stats Part I
Your note
Sign in to keep a note on AND — it syncs with the Stock Master app.